Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 14/20 | 1.00 |
| ▸ | HRH1 | P35367 | 9/20 | 1.00 |
| ▸ | HTR2C | P28335 | 8/20 | 0.70 |
| ▸ | DRD2 | P14416 | 1/20 | 0.57 |
| ▸ | DRD1 | P21728 | 1/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23242529 | 1.00 | HTR2A (1.00) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL23242568 | 0.93 | HTR2A (1.00) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL29800713 | 0.91 | HTR2A (0.83) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL23242584 | 0.91 | HTR2A (0.83) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL29800866 | 0.89 | HTR2A (1.00) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL23242504 | 0.89 | HTR2A (1.00) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL23242609 | 0.85 | HTR2A (1.00) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL23242540 | 0.85 | HTR2A (1.00) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL23242551 | 0.85 | HTR2A (1.00) | HTR2AHRH1HTR2CDRD2DRD1 | |
| SCHEMBL29800838 | 0.85 | HTR2A (1.00) | HTR2AHRH1HTR2CDRD2DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114929688-B | 3- (4- (11H-dibenzo [ b, e ] [1,4] azepin-6-yl) piperazin-1-yl) -and 3- (4- (dibenzo [ b, f ] [1,4] oxazepin/thiazepin/diazepin-11-yl) piperazin-1-yl) -propionic acid derivatives as H1 and 5-HT 2A-receptor modulators for the treatment of sleep disorders | 阿莱瑞恩公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-114929688-A | 3- (4- (11H-dibenzo [ b, e ] [1,4] azepin-6-yl) piperazin-1-yl) -and 3- (4- (dibenzo [ b, f ] [1,4] oxazepin/thiazepin/diazepin-11-yl) piperazin-1-yl) -propionic acid derivatives as H1 and 5-HT 2A-receptor modulators for the treatment of sleep disorders | 阿莱瑞恩公司 | 2022-08-19 | — | — | CN | disclosed |